Overview
In this report we highlight opportunities for wearable DHTs to provide a patient-centric measure for use in clinical research. This information is driven by the patient-reported experiences in the Voice of the Patient Report associated with the FDA’s Patient-Focused Drug Development initiative.
We hope this information facilitates the consideration of digital measures as clinical development teams plan and execute their clinical trials.
This Idiopathic Pulmonary Fibrosis specific Digital Measure Report includes:
- Summary of the most significant symptoms reported by patients with Idiopathic Pulmonary Fibrosis and how these symptoms manifest in patients’ everyday lives
- Identified meaningful aspects of health based on the symptoms described
- Descriptions of candidate digital measures that can collect relevant data to provide clinical insights that are meaningful to patients with Idiopathic Pulmonary Fibrosis
- A link to the full Idiopathic Pulmonary Fibrosis Voice of the Patient Report
Related Resources: